Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 mai 2026 08h35 HE | Source: 24/7 Market News and NeOnc Technology

Where Executives Are Doubling Down on Their Companies’ Fortunes

Insiders are buying shares of $NTHI, $RIVN, $SRAD, $NWBI, and $FGBI
06 mai 2026 08h30 HE | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a...
06 mai 2026 08h30 HE | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused...
06 mai 2026 06h00 HE | Source: Gigamon Inc

Gigamon 2026 Survey: AI Now Drives 83 Percent of Breaches as Attackers Outpace Defenders

Gigamon released its 2026 Hybrid Cloud Security Survey, revealing AI’s impact on the shifting cyber threat landscape as attackers outpace defenders.
05 mai 2026 13h20 HE | Source: Global Virus Network

Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance

For hantavirus cluster, experts emphasize caution while underscoring the importance of environmental controls, early detection, and clear communication.
05 mai 2026 09h30 HE | Source: Causal Dynamics Lab

Causal Dynamics Lab outperforms Anthropic and OpenAI in multiple coding tests

Causal Dynamics Lab flagship product Cielara Code beat both Claude Code (Opus-4.6) and OpenAI Codex (GPT-5.4).
05 mai 2026 03h00 HE | Source: Cytospire

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and...
04 mai 2026 10h00 HE | Source: Ovarian Cancer Canada

Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”

This research investment will enable Dr. Jeanette Boudreau to prepare powerful natural killer cell immunotherapy to move into clinical trials
04 mai 2026 09h00 HE | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

Oncolytics announced new data in metastatic colorectal cancer, demonstrating 3-4x improvement in duration response vs. historical 4-6 month benchmark.
04 mai 2026 08h00 HE | Source: Artios Pharma

Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution

Jeremy B. Fitch, MBA, appointed as Chief Business OfficerMichael A. Alrutz, J.D., Ph.D., appointed as General CounselGuy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United...

Page suivante